Suppr超能文献

间充质干细胞的显著特征——对尤文肉瘤建模的启示。

Salient features of mesenchymal stem cells-implications for Ewing sarcoma modeling.

机构信息

Sarcoma Services, Department of Orthopaedic Surgery, Huntsman Cancer Institute, University of Utah Salt Lake City, UT, USA.

出版信息

Front Oncol. 2013 Feb 25;3:24. doi: 10.3389/fonc.2013.00024. eCollection 2013.

Abstract

Despite a heightened appreciation of the many defining molecular aberrations in Ewing sarcoma, the cooperative genetic environment and permissive cell of origin essential for EWS/ETS-mediated oncogenesis remain elusive. Consequently, inducible animal and in vitro models of Ewing sarcoma from a native cellular context are unable to fully recapitulate malignant transformation. Despite these shortcomings, human, and murine mesenchymal stem cells (MSCs) are the closest working in vitro systems available. MSCs are tolerant of ectopic EWS/FLI expression, which is accompanied by a molecular signature most similar to Ewing sarcoma. Whether MSCs are the elusive cell of origin or simply a tolerant platform of the EWS/FLI transcriptome, these cells have become an excellent molecular tool to investigate and manipulate oncogenesis in Ewing sarcoma. Our understanding of the biological complexity and heterogeneity of human MSCs (hMSCs) has increased substantially over time and as such, appreciation and utilization of these salient complexities may greatly enhance the efficient use of these cells as surrogate models for Ewing sarcoma tumorigenesis.

摘要

尽管人们对尤文肉瘤中许多明显的分子异常有了更深入的了解,但 EWS/ETS 介导的致癌作用所必需的协同遗传环境和允许的细胞起源仍然难以捉摸。因此,源自天然细胞环境的尤文肉瘤的诱导型动物和体外模型无法完全再现恶性转化。尽管存在这些缺陷,但人类和鼠类间充质干细胞(MSCs)是最接近的可用体外系统。MSCs 能容忍异位 EWS/FLI 表达,同时伴有与尤文肉瘤最相似的分子特征。MSCs 是难以捉摸的起源细胞,还是 EWS/FLI 转录组的简单耐受平台,这些细胞已成为研究和操纵尤文肉瘤发生的极好的分子工具。随着时间的推移,我们对人类间充质干细胞(hMSCs)的生物学复杂性和异质性的理解有了很大的提高,因此,对这些显著复杂性的认识和利用可能会极大地提高这些细胞作为尤文肉瘤肿瘤发生替代模型的使用效率。

相似文献

1
Salient features of mesenchymal stem cells-implications for Ewing sarcoma modeling.
Front Oncol. 2013 Feb 25;3:24. doi: 10.3389/fonc.2013.00024. eCollection 2013.
2
Loss of Stag2 cooperates with EWS-FLI1 to transform murine Mesenchymal stem cells.
BMC Cancer. 2020 Jan 2;20(1):3. doi: 10.1186/s12885-019-6465-8.
4
The role of FLI-1-EWS, a fusion gene reciprocal to EWS-FLI-1, in Ewing sarcoma.
Genes Cancer. 2015 Nov;6(11-12):452-61. doi: 10.18632/genesandcancer.86.
5
Microsatellites with macro-influence in ewing sarcoma.
Genes (Basel). 2012 Jul 23;3(3):444-60. doi: 10.3390/genes3030444.
7
EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma.
Cancer Sci. 2018 Sep;109(9):2907-2918. doi: 10.1111/cas.13710. Epub 2018 Jul 18.
9
Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis.
J Clin Invest. 2014 Dec;124(12):5275-90. doi: 10.1172/JCI72124. Epub 2014 Nov 17.
10
EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.
Cancer Res. 2008 Apr 1;68(7):2176-85. doi: 10.1158/0008-5472.CAN-07-1761.

引用本文的文献

1
New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma.
Front Immunol. 2025 Jan 17;15:1539696. doi: 10.3389/fimmu.2024.1539696. eCollection 2024.
2
Challenges in modeling EWS-FLI1-driven transgenic mouse model for Ewing sarcoma.
Am J Transl Res. 2021 Nov 15;13(11):12181-12194. eCollection 2021.
3
Identification and Validation of Housekeeping Genes for Gene Expression Analysis of Cancer Stem Cells.
PLoS One. 2016 Feb 19;11(2):e0149481. doi: 10.1371/journal.pone.0149481. eCollection 2016.
4
Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.
Neuropeptides. 2016 Feb;55:55-66. doi: 10.1016/j.npep.2015.10.005. Epub 2015 Oct 26.
5
Targeted therapies for advanced Ewing sarcoma family of tumors.
Cancer Treat Rev. 2015 May;41(5):391-400. doi: 10.1016/j.ctrv.2015.03.008. Epub 2015 Mar 27.
6
3D tissue-engineered model of Ewing's sarcoma.
Adv Drug Deliv Rev. 2014 Dec 15;79-80:155-71. doi: 10.1016/j.addr.2014.07.012. Epub 2014 Aug 7.
7
RETRACTED: Combining PARP-1 inhibition and radiation in Ewing sarcoma results in lethal DNA damage.
Mol Cancer Ther. 2013 Nov;12(11):2591-600. doi: 10.1158/1535-7163.MCT-13-0338. Epub 2013 Aug 21.

本文引用的文献

2
Promiscuous partnerships in Ewing's sarcoma.
Cancer Genet. 2011 Jul;204(7):351-65. doi: 10.1016/j.cancergen.2011.07.008.
4
Modeling initiation of Ewing sarcoma in human neural crest cells.
PLoS One. 2011 Apr 29;6(4):e19305. doi: 10.1371/journal.pone.0019305.
8
Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing's Sarcoma.
Genes Cancer. 2010 Feb 1;1(2):177-187. doi: 10.1177/1947601910361495.
9
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.
Nature. 2010 Aug 12;466(7308):829-34. doi: 10.1038/nature09262.
10
The Ewing's sarcoma fusion protein, EWS-FLI, binds Runx2 and blocks osteoblast differentiation.
J Cell Biochem. 2010 Nov 1;111(4):933-43. doi: 10.1002/jcb.22782.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验